Approval watch

Selected products up for approval in 2009. (A) Endo (NASDAQ:ENDP) is acquiringIndevus (NASDAQ:IDEV); (B) FDA missed Sept. 26, 2008 PDUFA date; (C) For Myozyme alglucosidase produced at the 2,000 liter...